Real Estate Leads Healthy Recovery In Emerging Markets
The emerging markets (EMs) have seen a vast improvement in their economic outlook in the past few months. Many Asian EMs have already seen a swing back to expansionary numbers, while the ones in Latin America (LATAM), Europe, Middle East and Africa (EMEA) are seeing a
The emerging markets (EMs) have seen a vast improvement in their economic outlook in the past few months. Many Asian EMs have already seen a swing back to expansionary numbers, while the ones in Latin America (LATAM), Europe, Middle East and Africa (EMEA) are seeing a surge in recovery momentum, despite their ongoing battle with COVID-19. The Manufacturing PMI, a leading indicator of economic activity, has rebounded firmly since August for most EMs, and exceeded the developed markets significantly, as per iFast Research, SingaporeLooking forward to 2021, the combination of: i) cyclical recovery, ii) weakening USD, iii) commodity upcycle and iv) continuation of China’s strong recovery should uplift EM’s growth. A vaccine approval next year will be a huge catalyst. Of these, the US dollar weakness and commodity upcycle are likely to be long-term tailwinds, indicating a multi-year positive set-up for EM equities, which have strong inverse correlations with these factors.Supported by robust double-digit earnings growth projected for the next two years, EM equities (gauged by MSCI EM index), in aggregate, are set to deliver a potential upside of 18 percent by end-2022, despite the elevated valuation. Due to EMs’ sensitivity to global demand (i.e., exports-focus, heavy commodity exposure), a cyclical recovery can significantly uplift growth in these markets. Based on previous crises, we see that EMs typically register a stellar growth rate of above 5 percent after an economic trough. The recent slew of vaccine news spell another positive for EMs. a vaccine approval (unless late in 2021) should amplify the cyclical recovery, setting the stage for a synchronised global demand rebound.